Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine for postoperative pain and early recovery after abdominal surgery
ChiCTR2200062921Phase 4Not yet recruiting
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in postoperative pain (4 arms), sponsored by Tumor Hospital Affiliated to Guizhou Medical University. Primary endpoints: Proportion of moderate to severe pain at rest and during movement at 24 hours after surgery, Awakening time from anesthesia and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2200062921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062921.